Rural cardiovascular disparities and limited specialist access are motivating AI decision-support adoption to help determine ...

In this episode, Overcoming Access Barriers and Step-Edit Challenges in IgA Nephropathy Care, the panelists explore the ...

An investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist, orforglipron (Eli Lilly), demonstrated superior ...

As prescription drug pricing grows increasingly complex, Eric Levin, CEO and cofounder of Scripta, says Scripta aims to simplify the process for consumers trying to find the right medication at the ...

The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...

Measles outbreaks are emerging across the country, continuing the increasing trend in cases that began in 2025.

Emerging CRC diagnostic tools along with better public awareness could help reverse rising deaths in younger adults, says ...

ACOs entering MSSP with higher spending were consistently more likely to earn bonuses—a gap that persisted after a 2017 ...

Bhavana (Tina) Bhatnagar, DO, advocates for AI and diverse clinical trials to bridge equity gaps in precision oncology and value-based care.

Organ transplant recipients (OTRs) treated with azathioprine (AZA) face an increased risk for nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), according to an updated ...

Today, the FDA granted accelerated approval to zongertinib (Hernexeos; Boehringer Ingelheim Pharmaceuticals, Inc.) for an expanded indication for adults with unresectable or metastatic non-squamous ...

Reducing administrative burden is treated as a strategic lever to improve clinical throughput and patient care quality by ...